Daniel Knott
Impact in
-
- Schizophrenia research and treatment
- Epilepsy research and treatment
- Electroconvulsive Therapy Studies
-
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease and Spinal Disorders
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
-
- Respiratory viral infections research 1
- Co-authors
- Kristopher L. Arheart (1 shared paper)Reed Johnson (1 shared paper)Patricia A. Marken (1 shared paper)Brian Wells (1 shared paper)Stuart Dowall (1 shared paper)Luc Gagnon (1 shared paper)Sue Charlton (1 shared paper)Roger Hewson (1 shared paper)
- Journals
- Human Vaccines & Immunotherapeutics (1 paper)Viruses (1 paper)PubMed (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Daniel Knott
3 papers receiving 18 citations
Peers
Comparison fields: 5 of 15
- Psychiatry and Mental health 11
- Neurology 5
- Infectious Diseases 3
- Obstetrics and Gynecology 1
- Endocrinology, Diabetes and Metabolism 2
Countries citing papers authored by Daniel Knott
This map shows the geographic impact of Daniel Knott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Knott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Knott more than expected).
Fields of papers citing papers by Daniel Knott
This network shows the impact of papers produced by Daniel Knott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Knott. The network helps show where Daniel Knott may publish in the future.
Co-authors
The 15 scholars most cited alongside Daniel Knott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia. | 1991 | 15 |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 |
About Daniel Knott
Daniel Knott is a scholar working on Infectious Diseases, Epidemiology, Computational Theory and Mathematics, Immunology and Organic Chemistry, having authored 3 papers that have together received 20 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Computational Drug Discovery Methods (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Psychiatry and Mental health (11 citations), Neurology (5 citations), Infectious Diseases (3 citations), Obstetrics and Gynecology (1 citation) and Endocrinology, Diabetes and Metabolism (2 citations). Daniel Knott has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Kristopher L. Arheart, Reed Johnson, Patricia A. Marken, Brian Wells, Stuart Dowall, Luc Gagnon, Sue Charlton, Roger Hewson, Pamela C. Proud and Francisco J. Salguero. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Viruses and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.